1. Home
  2. GTIM vs LNAI Comparison

GTIM vs LNAI Comparison

Compare GTIM & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

HOLD

Current Price

$1.31

Market Cap

13.7M

ML Signal

HOLD

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

HOLD

Current Price

$4.15

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTIM
LNAI
Founded
1987
N/A
Country
United States
United States
Employees
N/A
29
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
11.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
GTIM
LNAI
Price
$1.31
$4.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.1K
684.6K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$142,315,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$44.67
N/A
Revenue Growth
3.01
N/A
52 Week Low
$1.10
$0.15
52 Week High
$2.09
$5.02

Technical Indicators

Market Signals
Indicator
GTIM
LNAI
Relative Strength Index (RSI) 58.05 80.02
Support Level $1.25 $0.53
Resistance Level $1.34 N/A
Average True Range (ATR) 0.03 0.47
MACD 0.00 0.11
Stochastic Oscillator 66.67 77.98

Price Performance

Historical Comparison
GTIM
LNAI

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: